Assessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPD-Reference-Cited by-同舟云学术

Assessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPD

Published:2015-04 Issue: Volume:31 Page:68-78
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Cazzola Mario,Beeh Kai M.,Price David,Roche Nicolas

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry, medical,Pulmonary and Respiratory Medicine

Reference123 articles.

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. Updated 2014. [accessed 21.07.2014] http://www.goldcopd.org/.

2. The role of bronchodilator treatment in the prevention of exacerbations of COPD;Wedzicha;Eur Respir J,2012

3. No room to breathe: the importance of lung hyperinflation in COPD;Thomas;Prim Care Respir J,2013

4. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study;Celli;Am J Respir Crit Care Med,2008

5. Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial;Troosters;Eur Respir J,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is it preferable to administer a bronchodilator once- or twice-daily when treating COPD?;Respiratory Medicine;2023-11

2. Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases;The Journal of Allergy and Clinical Immunology: In Practice;2022-06

3. Cost-Effectiveness of Once-Daily, Single-Inhaler Indacaterol Acetate/ Glycopyrronium Bromide/ Mometasone Furoate in Patients with Uncontrolled Moderate-to-Severe Asthma in Canada;ClinicoEconomics and Outcomes Research;2021-12

4. Research Advances in COPD Drugs and Novel Targets;Nano LIFE;2021-09

5. Pharmacological targets and emerging treatments for respiratory syncytial virus bronchiolitis;Pharmacology & Therapeutics;2021-04